Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Ovid Therapeutics (OVID) had Free Cash Flow per Share of $-0.21 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$6.27M |
|
$-4.68M |
|
-- |
|
$6.27M |
|
$11.35M |
|
$-5.07M |
|
$0.39M |
|
$-4.68M |
|
$-4.68M |
|
$-4.68M |
|
$-4.68M |
|
$-4.68M |
|
$-4.68M |
|
$-5.07M |
|
$-4.97M |
|
71.11M |
|
71.11M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$42.09M |
|
$0.28M |
|
$35.34M |
|
$77.43M |
|
$8.92M |
|
$12.71M |
|
$12.71M |
|
$21.64M |
|
$55.79M |
|
$55.79M |
|
$55.79M |
|
71.11M |
|
| Cash Flow Statement Financials | |
$-15.05M |
|
$17.16M |
|
$0.01M |
|
$28.23M |
|
$30.35M |
|
$2.11M |
|
$2.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.72 |
|
-- |
|
-- |
|
0.19 |
|
0.25 |
|
100.00% |
|
-80.88% |
|
-80.88% |
|
-- |
|
-74.68% |
|
-74.68% |
|
$-15.05M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
-8.40% |
|
-8.40% |
|
-6.05% |
|
-6.84% |
|
$0.78 |
|
|
Free Cash Flow per Share |
$-0.21 |
$-0.21 |
|